Can PDT be potentiated by immunotherapy?

Two principal aspects of interlinkage of the immune system with photodynamic therapy (PDT) treatment are discussed in detail: (1) participation of tumor associated macrophages (TAM) in tumor localization of photosensitizers, and (2) induction of an inflammatory immune response by phototoxic effects in endothelial cells, TAM and other cells in the tumor, leading to necrosis of the tumor tissue. It is illustrated how Photofrin levels in TAM, and consequently in the tumor as a whole, can be altered (increased or decreased) by specific agents that stimulate or impair physiological processes in TAM. It is suggested that the selectivity of tumor localization of some photosensitizers can be augmented by TAM targeted immunotherapy with agents that enhance the rate of tumor infiltration of these cells and stimulate their phagocytic activity. Preliminary results of ongoing studies suggest that PDT induces a massive infiltration of immune cells into the treated tumor. It is hypothesized that by combining PDT with an appropriate type of immunotherapy the immune reaction can be potentiated and directed against the surviving tumor cells. As as an example, it is shown that much better control of SCCVII tumor is achieved by combining PDT with the treatment by the immunoactivator SPG compared to PDT alone.

[1]  G. Adams,et al.  Radiosensitization in vivo: a study with an homologous series of 2-nitroimidazoles. , 1983, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[2]  R. Keck,et al.  MORPHOLOGICAL CHANGES OF TUMOR MICROVASCULATURE FOLLOWING HEMATOPORPHYRIN DERIVATIVE SENSITIZED PHOTODYNAMIC THERAPY * , 1987, Photochemistry and photobiology.

[3]  N. Yamamoto,et al.  Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. , 1988, Cancer research.

[4]  U. Nseyo,et al.  Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. , 1990, Urology.

[5]  C J Gomer,et al.  Properties and applications of photodynamic therapy. , 1989, Radiation research.

[6]  S. Eccles,et al.  Macrophage content of tumours in relation to metastatic spread and host immune reaction , 1974, Nature.

[7]  R. Straight,et al.  SYSTEMIC IMMUNOSUPPRESSION INDUCED BY PHOTODYNAMIC THERAPY (PDT) IS ADOPTIVELY TRANSFERRED BY MACROPHAGES , 1989, Photochemistry and photobiology.

[8]  M. Korbelik,et al.  Photofrin uptake by murine macrophages. , 1991, Cancer research.

[9]  D. Bellnier.  Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha. , 1991, Journal of photochemistry and photobiology. B, Biology.

[10]  J. Norton,et al.  Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. , 1990, Journal of the National Cancer Institute.

[11]  J K Hoober,et al.  Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light. , 1991, European journal of cancer.

[12]  L. Milas,et al.  Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. , 1987, Cancer research.

[13]  T. Dougherty,et al.  Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. , 1981, Cancer research.

[14]  J. Marshall,et al.  Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors. , 1988, Cancer research.

[15]  B. Henderson,et al.  Release of prostaglandin E2 from cells by photodynamic treatment in vitro. , 1989, Cancer research.

[16]  I. Sugawara,et al.  Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells , 2004, Cancer Immunology, Immunotherapy.